Exam 3 all prototypes

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/197

encourage image

There's no tags or description

Looks like no tags are added yet.

198 Terms

1
New cards

Enoxaparin (Lovenox) type

Low molecular weight heparin (LMWH).

2
New cards

Enoxaparin (Lovenox)Therapeutic class

Parenteral anticoagulant.

3
New cards

Enoxaparin (Lovenox) Pharmacologic class

Indirect thrombin inhibitor.

4
New cards

Enoxaparin (Lovenox)Route and onset

Given subcutaneously with about a 1-hour onset.

5
New cards

Enoxaparin (Lovenox)Duration of action

About 12 hours (2-4x longer than heparin).

6
New cards

Enoxaparin (Lovenox) Monitoring requirements

No efficacy labs needed; monitor platelet counts.

7
New cards

Enoxaparin (Lovenox) Normal platelet range

150,000 to 450,000.

8
New cards

Enoxaparin (Lovenox) Dosage determination

Based on patient weight.

9
New cards

Enoxaparin (Lovenox) Advantages over heparin

Longer duration, more stable, no aPTT monitoring, home use.

10
New cards

Enoxaparin (Lovenox) Antidote

Protamine sulfate.

11
New cards

Alteplase therapeutic class

Drug for dissolving clots ("clot buster").

12
New cards

Alteplase pharmacologic class

Thrombolytic.

13
New cards

Alteplase mechanism of action

Converts plasminogen to plasmin, dissolving fibrin clots.

14
New cards

Alteplase off-label use

To restore patency to IV catheters.

15
New cards

Alteplase administration window for MI

Within 12 hours of symptom onset.

16
New cards

Alteplase administration window for stroke

Within 3 to 4 hours of stroke.

17
New cards

Alteplase most common adverse effect

Bleeding.

18
New cards

Alteplase other adverse effects

Anaphylaxis.

19
New cards

Alteplase contraindications

Active internal bleeding, recent stroke, or recent surgery.

20
New cards

Alteplase drug interactions

Other anticoagulants, ginkgo, and garlic.

21
New cards

Clopidogrel Therapeutic Class

Antiplatelet drug

22
New cards

Clopidogrel Pharmacologic Class

Adenosine diphosphate (ADP) receptor blocker

23
New cards

Clopidogrel Action (Ischemic events)

Reduces rate of MI or stroke in acute STEMI, unstable angina, or NSTEMI

24
New cards

Clopidogrel Action (Stents)

Prevents thrombi in coronary stents

25
New cards

Clopidogrel Administration (Pills)

Do not crush pills or tablets

26
New cards

Clopidogrel Administration (Surgery)

Discontinue 5 days prior to surgery

27
New cards

Clopidogrel Adverse Effects

Generally well tolerated, bruising, rash, and flu-like symptoms

28
New cards

Clopidogrel Black Box Warning

Ineffective for poor metabolizers (Cyp 450); >50% of Asians have inhibiting variants

29
New cards

Clopidogrel Contraindication

Active bleeding

30
New cards

Clopidogrel Drug Interactions (Drugs)

Other anticoagulants and NSAIDs increase bleeding risk

31
New cards

Clopidogrel Drug Interactions (Herbs)

Herbs affecting coagulation like ginkgo, ginger, and garlic

32
New cards

Warfarin Therapeutic Class

Oral anticoagulant.

33
New cards

Warfarin Pharmacologic Class

Vitamin K antagonist.

34
New cards

Warfarin Mechanism of Action

Inhibits Vitamin K action to prevent stroke, DVT, and pulmonary embolism.

35
New cards

Warfarin Indications

Prevents clotting events following an MI or atrial fibrillation.

36
New cards

Warfarin Primary Adverse Effect

Severe bleeding; remains in the system up to 10 days after stopping.

37
New cards

Warfarin Contraindications

Recent trauma, active internal bleeding, bleeding disorders, intracranial hemorrhage, severe HTN, or severe liver/kidney disease.

38
New cards

Why is Warfarin overlapped with Heparin?

Warfarin takes 3 to 5 days to achieve therapeutic anticoagulation.

39
New cards

Warfarin Lab Monitoring

Prothrombin Time (PT) measured by INR.

40
New cards

Warfarin Therapeutic INR Goal

2.0 to 3.0.

41
New cards

Warfarin Antidote

Vitamin K (PO or IV).

42
New cards

Warfarin Boxed Warning (BBW)

Can cause life-threatening or fatal bleeding; regular INR monitoring is required.

43
New cards

Heparin: Therapeutic Class

Anticoagulant (parenteral)

44
New cards

Heparin: Pharmacologic Class

Indirect thrombin inhibitor

45
New cards

Heparin: Mechanism of Action

Inactivates clotting factors to immediately prevent further clot formation.

46
New cards

Heparin: Onset and Duration

Fast onset (within minutes to 1 hour) and fast off-set (IV).

47
New cards

Heparin: Lab Monitoring

aPTT (target: 2x client baseline / 25-40 seconds).

48
New cards

Heparin: Antidote

Protamine sulfate

49
New cards

Heparin: Administration

SQ injection given 2 inches away from the umbilicus.

50
New cards

Heparin: Adverse Effects

Abnormal bleeding, epidural or spinal hematoma, and HIT.

51
New cards

Heparin: Contraindications

Active bleeding, bleeding disorders, and intracranial hemorrhage.

52
New cards

Heparin: Interactions

Other anticoagulants, aspirin, nicotine, digoxin, and tetracyclines.

53
New cards

Milrinone Therapeutic Class

Drug for acute heart failure

54
New cards

Milrinone Pharmacologic Class

Phosphodiesterase (PDE) inhibitor

55
New cards

Milrinone Mechanism of Action

Blocks phosphodiesterase in cardiac and smooth muscle

56
New cards

Milrinone effect on cardiac output

Increases force of contraction and cardiac output

57
New cards

Milrinone administration route and half-life

Given IV; short half-life of ~2.5 hours

58
New cards

Milrinone effect on the heart

Increases calcium availability to heart muscle to increase contraction

59
New cards

Milrinone effect on vessels

Increases cAMP causing vasodilation, reducing preload and afterload

60
New cards

Milrinone major adverse effect

Ventricular dysrhythmias

61
New cards

Electrolyte to correct before giving milrinone

Hypokalemia, to reduce dysrhythmia risk

62
New cards

Milrinone overdose management

Slow or stop infusion; supportive care for hypotension

63
New cards

Milrinone overdose antidote

None exists; use supportive care

64
New cards

Digoxin (Lanoxin) Therapeutic Class

Drug for heart failure

65
New cards

Digoxin Pharmacologic Class

Cardiac glycoside

66
New cards

Digoxin effect on heart contractility

Increases contractility (positive inotrope)

67
New cards

Enzyme inhibited by digoxin

Na+K+ ATPase

68
New cards

Digoxin mechanism on calcium release

Accumulated sodium causes release of stored calcium ions

69
New cards

Digoxin effect on cardiac output and urine

Increases cardiac output and urine production

70
New cards

Symptoms relieved by digoxin

Pulmonary congestion and peripheral edema

71
New cards

Digoxin effect on vagal tone and heart rate

Increases vagal tone, slowing heart rate

72
New cards

Digoxin Administration Alert - Pulse

Take apical pulse for 1 full minute. Withhold if HR less than parameter (usually < 60 bpm) and notify provider.

73
New cards

Digoxin Lab Monitoring

Monitor serum digoxin level & K+ (therapeutic range: 0.5-2.0 ng/mL; HF target 0.5-0.9).

74
New cards

Digoxin Use in Elderly and Pediatric Patients

Use cautiously due to renal and hepatic immaturity or decreased function.

75
New cards

Digoxin & Diuretics Interaction

Loop/thiazide diuretics cause hypokalemia -> increased digoxin toxicity & dysrhythmias.

76
New cards

Digoxin Contraindications

Do not give to those with AV block or ventricular arrhythmia's unrelated to HF.

77
New cards

Digoxin Drug Interactions (Levels)

Amiodarone, verapamil & quinidine increase digoxin levels.

78
New cards

Digoxin Drug Interactions (Potassium)

ACEi/ARBs/spironolactone can cause hyperkalemia.

79
New cards

Digoxin Antidote

digoxin immune Fab (DigiFab).

80
New cards

Nifedipine (Procardia) - Therapeutic Class

Drug for hypertension and angina.

81
New cards

Nifedipine (Procardia) - Pharmacologic Class

Calcium channel blocker (CCB-dihydropyridine).

82
New cards

Nifedipine mechanism of action

Blocks calcium channels in myocardial and vascular smooth muscle.

83
New cards

Nifedipine hemodynamic effects

Coronary artery dilation, reduced oxygen use, increased CO, decreased peripheral resistance.

84
New cards

Nifedipine common side effects

Fatigue, dizziness, hypotension, peripheral edema, headache, and reflex tachycardia.

85
New cards

Nifedipine drug interactions

Other antihypertensives and alcohol (potentiates vasodilation).

86
New cards

Nifedipine dietary restriction

Do not take with grapefruit juice.

87
New cards

Nifedipine and CYP3A4 enzymes

Can increase the effect of statin drugs.

88
New cards

Metoprolol (Lopressor, Toprol XL) Therapeutic class:

Drug for hypertension and heart failure.

89
New cards

Metoprolol Pharmacologic Class

Beta-adrenergic blocker (beta blocker) - selective for B1.

90
New cards

Metoprolol Action

Reduces sympathetic stimulation of the heart, decreasing cardiac workload.

91
New cards

Metoprolol Respiratory Advantage

Preferred for patients with respiratory disease due to cardio-selective B1 action.

92
New cards

Metoprolol Side Effects

Hypotension, bradycardia, fatigue, exercise intolerance, and erectile dysfunction (ED).

93
New cards

Metoprolol Administration Assessment

Assess pulse and blood pressure prior to administration (hold if <60 bpm or hypotensive).

94
New cards

Metoprolol Drug Interactions

Concurrent digoxin causes bradycardia; antihypertensives may enhance hypoglycemic effects and mask low blood sugar signs.

95
New cards

Metoprolol Black Box Warning

Acute withdrawal may worsen angina or cause myocardial infarction; taper off over a few weeks.

96
New cards

Metoprolol Contraindications

Heart block, cardiogenic shock, and hypotension.

97
New cards

Losartan Therapeutic Class

Drug for hypertension

98
New cards

Losartan Pharmacologic Class

Angiotensin II receptor blocker

99
New cards

Losartan Action

Blocks angiotensin receptors in vascular smooth muscle, causing vasodilation and reduced blood volume.

100
New cards

Losartan Side Effects

Hyperkalemia, dizziness, stuffy nose, fatigue, hypotension, and altered renal function.